Finance LINAC systems, proton therapy, and radiation oncology equipment β $1M to $5M+.
No cost, no obligation, no credit impact.
Bank-level encryption. Your info is confidential.
Trusted by 1,000+ businesses nationwide
"I've worked with Brobas for a long time. They provided financing with a minimal down payment, which was crucial for me. Since then, I've grown with them and plan to open a fourth location."
Nikola T.
Fleet Owner
"The first day after submitting documents, they gave me a full breakdown of my situation and explained the strategy. I got a great offer, and now the truck works for me β not the other way around."
Oleh O.
Owner-Operator
"Brobas has great relationships with banks. The monthly payment they offered was comparable, if not lower, than equipment financing. You won't get the same terms walking into a street bank."
Natalya P.
Business Owner
Radiation therapy equipment represents the highest-value medical technology investment. Linear accelerators from Varian, Elekta, and Accuray range from $1M to $5M+, with vault construction adding another $1M-$3M. Brobas Capital Partners works with specialized oncology equipment lenders who understand the complex revenue models of radiation therapy programs. Whether you're a hospital adding a radiation oncology department or a freestanding cancer center upgrading technology, we structure financing that aligns with your program's growth trajectory.
Finance LINAC systems from $1M to $5M+ with terms up to 84 months.
Bundle radiation vault construction ($1M-$3M), shielding, and site prep into your equipment financing.
Lenders who understand radiation oncology reimbursement, treatment planning, and patient volume projections.
Structured financing with built-in upgrade paths as LINAC technology evolves.
Fill out a quick 5-minute application. No impact on your credit score.
Our AI engine matches you with the best lenders from our 500+ network.
Review competitive offers with transparent rates and terms.
Choose your best option and receive funding β often within days.
β’ $3,800,000 Varian TrueBeam + Vault Construction β Community cancer center, 18 years, 750 credit. 5.24% APR, 84 months, 10% down. Total project including vault: $5,200,000.
β’ $2,400,000 Elekta Versa HD β Hospital radiation oncology department upgrade, 745 credit. 5.49% APR, 84 months, 5% down.
β’ $4,200,000 Accuray CyberKnife M6 β Freestanding cancer center, 12 years, 735 credit. 5.49% APR, 84 months, MLA structure.
β’ $1,800,000 Varian Halcyon β New radiation therapy program for regional hospital, 730 credit. 5.74% APR, 72 months, 15% down.
Market Analysis: Before investing $3M-$8M+ in radiation therapy, analyze your service area. Key metrics include cancer incidence rates, existing radiation therapy capacity, referral patterns, and payer mix. Most programs need a catchment area of 200,000+ population to support a single LINAC.
Staffing Requirements: A LINAC requires a radiation oncologist ($400K-$600K/year), medical physicist ($150K-$250K), dosimetrist ($100K-$150K), and 2-3 radiation therapists ($80K-$120K each). Total staffing costs of $800K-$1.2M/year.
Regulatory & Accreditation: NRC licensing, state radiation control permits, and ACR accreditation are required before treating patients. The regulatory process takes 6-12 months and should begin concurrently with construction.
Revenue Ramp-Up: Most new radiation therapy programs take 12-24 months to reach full patient volume. Structure your financing with deferred or graduated payments to match revenue growth.
Technology Selection: The Varian Halcyon offers a lower price point ($1.5M-$2M) and simplified workflow ideal for community hospitals. The TrueBeam and Elekta Versa HD offer maximum versatility for comprehensive cancer centers. The CyberKnife is specialized for SRS/SBRT programs.
New linear accelerators range from $1M for basic models to $5M+ for advanced systems with MLC, IGRT, SBRT, and SRS capabilities. The Varian TrueBeam costs $3M-$5M, Elekta Versa HD $2M-$4M, and Accuray CyberKnife $4M-$6M. Vault construction adds $1M-$3M.
A single LINAC treating 30-40 patients/day generates $3M-$8M+ in annual revenue. SBRT and SRS treatments command premium reimbursement of $10,000-$30,000 per course. Most LINAC investments achieve ROI within 2-4 years.
Yes. Proton therapy systems ($25M-$200M+) require specialized financing structures. We work with lenders experienced in large-scale oncology capital projects, including syndicated financing for multi-room proton centers.
Absolutely. We finance treatment planning software (Eclipse, Monaco, RayStation), dosimetry equipment, simulation CT scanners, and all ancillary radiation therapy technology.
No cost, no obligation, no credit impact.
Bank-level encryption. Your info is confidential.